> navigate:  
  Academic Programs

PCOM School of Pharmacy Faculty

Mark Okamoto, PharmD

Dean & Chief Academic Officer
Tenured Professor of Pharmacy

 

Contact

Ph: 678-407-7340
FX: 678-407-7331
E-mail: mokamoto@pcom.edu

 

Education

PharmD, University of Southern California
Residency, General Medicine, Los Angeles County / U.S.C. Medical Center
Fellowship, Infectious Disease (Pharmacokinetics), Los Angeles County / U.S.C. Medical Center
Fellowship, Advanced Infectious Disease (Pharmacoeconomics), Los Angeles County / U.S.C. Medical Center

 

Honors/Awards

Rho Chi National Pharmaceutical Honor Society / University of Southern California. Limited to top 20% of the class
Dean’s List Scholar, 1986, 1987, 1988. Requires minimum GPA of 3.5 for consideration
Faculty Service Award / University of Southern California. Presented for meritorious service to the School
Clerkship of the Year / University of California, San Francisco. Presented for teaching excellence
Most Outstanding Faculty Member / Western University of Health Sciences, College of Pharmacy
Marquis Who’s Who in America
Who’s Who Among American Teachers
Teacher of the Year / Western University of Health Sciences
Teacher of the Year / PCOM School of Pharmacy
Peach Teaching Award

 

Selected Publications

Okamoto MP, Chin A, Gill MA. A comparison of two Bayesian pharmacokinetic programs in the prediction of serum gentamicin concentrations. Clinical Pharmacy (1990); 9:708-711.

Okamoto MP, Chin A, Gill MA, Sclar DA, Berne TV, Yellin AE, Heseltine PN, Appleman MD. Analysis of cefepime tissue penetration into human appendix. Pharmacotherapy (1991); 11:353-58.

Okamoto MP, Gill MA, Nakahiro RK, Bedikian A, Chin A, Yellin AE, Berne TV, Knupp CA. Cefepime pharmacokinetics in patients undergoing elective cholecystectomy. Clinical Pharmacv, (1993); 12:134-137.

Okamoto MP Nakahiro RK, Chin A, Bedikian A. Cefepime clincal pharmacokinetics. Clinical Pharmacokinetics (1993); 25(2): 88-102.

Okamoto MP, Ho, S. Evaluating the clinical literature. In: Millares M, ed. Applied Drug Information: Strategies for Information Management. Vancouver, WA: Applied Therapeutics, 1998: 6.1-6.49.

Bounthavong M, Okamoto MP. Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia. J Eval Clin Pract 2007; 13(3):453-460.

Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001; 21(11):1337-1344.

 

Selected Presentations

Okamoto MP. Tissue penetration of cefepime into human appendix. ACCP 11th annual meeting, San Francisco, CA (August, 1990)

Okamoto MP. Cefepime pharmacokinetics in plasma, peritoneal fluid, bile fluid, and gallbladder wall tissue. ACCP 12th Annual Meeting, Minneapolis, Minnesota (August, 1991).

Okamoto MP. Introduction to Pharmacoeconomics. Inland Society of Health-System Pharmacists. Riverside, CA. Continuing Education course (June 1999).

Okamoto MP. Pharmacoeconomics of cefmetazole versus cefoxitin in patients with penetrating abdominal trauma. Pfizer research forum (New York NY, April 1993).

 

Grants

1989 (PI). Tissue penetration of cefepime into human appendix. Bristol-Myers Squibb:

1990 (PI): Penetration of cefepime into gallbladder tissue in patients undergoing cholecystectomy. Bristol-Myers Squibb

1990 (PI). A cost benefit analysis of cefepime versus gentamicin/clindamycin in acute cholecystitis. Bristol -Myers Squibb:

1991 (Co-I). Cost-effectiveness of transdermal delivery systems for antihypertensive medication. Boehringer Ingelheim Pharmaceuticals, Inc.

1991 (Co-I). Determination of fluconazole in human serum by solid phase extraction and reversed phase HPLC. Glaxo Pharmaceuticals

1992 (PI). Pharmacoeconomic evaluation of a pharmacist managed hypertension clinic. The Upjohn Company

1994 (PI). The use of Alpha Adrenergic Blockers in the Treatment of Benign Prostatic Hypertrophy. Kaiser Permanente Regional Research Grant.

1997 (PI). Socioeconomic evaluation of fluoxetine, paroxetine and sertraline in a managed care setting. Eli Lilly and Company:

2003 (Co-PI). Evaluation of outcomes of community based disease state management programs: Asthma & Diabetes. Community Pharmacy Foundation

2009 (Co-I). Multi-scale analysis and knowledge structuring for natural products. National Science Foundation – Science and technology centers

 

Editorial Experience

Editorial Board

Annals of Pharmacotherapy (2003-present)
Chair – Medication Therapy Management section (2011-present)
Current Medicinal Chemistry – Anti Infective Agents (2000-present)

Peer Reviewer

International Society for Pharmacoeconomic & Outcomes Research (ISPOR) Pharmacoeconomics
Expert Review of Pharmacoeconomics & Outcomes Research
Annals of Pharmacotherapy
Pharmacotherapy
Journal of Pharmacy Technology
Clinical Pharmacy American Journal of Health-System Pharmacy
Clinical Therapeutics
Drugs
Clinical Drug Investigation
Clinical Pharmacokinetics
American Journal of Respiratory Medicine
Journal of Managed Care Pharmacy
Journal of Clinical Anesthesia 

Last Updated: 10/13/14